{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:45:07Z","timestamp":1792014307065,"version":"4.4.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2011,4,21]],"date-time":"2011-04-21T00:00:00Z","timestamp":1303344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Fractures are increased among men with prostate cancer, especially those on androgen-deprivation therapy (ADT), but few data are available on men with localized prostate cancer. The purpose of this investigation was to estimate fracture risk among unselected community men with prostate cancer and systematically assess associations with ADT and other risk factors for fracture. In a population-based retrospective cohort study, 742 Olmsted County, MN, men with prostate cancer first diagnosed in 1990\u20131999 (mean age 68.2\u2009\u00b1\u20098.9 years) were followed for 6821 person-years. We estimated cumulative fracture incidence, assessed relative risk by standardized incidence ratios, and evaluated risk factors in time-to-fracture regression models. All together, 482 fractures were observed in 258 men (71 per 1000 person-years). Overall fracture risk was elevated 1.9-fold, with an absolute increase in risk of 9%. Relative to rates among community men generally, fracture risk was increased even among men not on ADT but was elevated a further 1.7-fold among ADT-treated compared with untreated men with prostate cancer. The increased risk following various forms of ADT was accounted for mainly by associations with pathologic fractures (14% of all fractures). Among men not on ADT (62% of the cohort), more traditional osteoporosis risk factors were implicated. In both groups, underlying clinical characteristics prompting different treatments (indication bias) may have been partially responsible for the associations seen with specific therapies. To the extent that advanced-stage disease and pathologic fractures account for the excess risk, the effectiveness of fracture prevention among men with prostate cancer may be limited. \u00a9 2011 American Society for Bone and Mineral Research<\/jats:p>","DOI":"10.1002\/jbmr.405","type":"journal-article","created":{"date-parts":[[2011,4,21]],"date-time":"2011-04-21T18:51:43Z","timestamp":1303411903000},"page":"1808-1815","source":"Crossref","is-referenced-by-count":47,"title":["Fracture risk in men with prostate cancer: A population-based study"],"prefix":"10.1093","volume":"26","author":[{"suffix":"III","given":"L Joseph","family":"Melton","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Internal Medicine, College of Medicine, Mayo Clinic, Rochester, MN, USA"},{"name":"Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M","family":"Lieber","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J","family":"Achenbach","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Zincke","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry M","family":"Therneau","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Khosla","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Internal Medicine, College of Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,4,21]]},"reference":[{"key":"2024020318013391600_bib1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jcem.87.4.8417","article-title":"Clinical review 144: Estrogen and the male skeleton","volume":"87","author":"Khosla","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318013391600_bib2","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/01.ju.0000059281.67667.97","article-title":"Fracture risk following bilateral orchiectomy","volume":"169","author":"Melton","year":"2003","journal-title":"J Urol."},{"key":"2024020318013391600_bib3","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.4065\/76.12.1199","article-title":"Decline in bilateral orchiectomy for prostate cancer in Olmsted County, Minnesota, 1956\u20132000","volume":"76","author":"Melton","year":"2001","journal-title":"Mayo Clin Proc."},{"key":"2024020318013391600_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpuro0995","article-title":"Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?","volume":"5","author":"Higano","year":"2008","journal-title":"Nat Clin Pract Urol."},{"key":"2024020318013391600_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.pcan.4501019","article-title":"Bone health in prostate cancer patients receiving androgen-deprivation therapy: the role of bisphosphonates","volume":"11","author":"Polascik","year":"2008","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2024020318013391600_bib6","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/jnci\/92.21.1731","article-title":"Cost-effectiveness of androgen suppression therapies in advanced prostate cancer","volume":"92","author":"Bayoumi","year":"2000","journal-title":"J Natl Cancer Inst."},{"key":"2024020318013391600_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin."},{"key":"2024020318013391600_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-152-10-201005180-00002","article-title":"Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancer","volume":"152","author":"Ito","year":"2010","journal-title":"Ann Intern Med."},{"key":"2024020318013391600_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bone.2008.05.003","article-title":"Incidence and risk factors for low trauma fractures in men with prostate cancer","volume":"43","author":"Ahlborg","year":"2008","journal-title":"Bone."},{"key":"2024020318013391600_bib10","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ju.0000143930.73016.c6","article-title":"Hip fractures in men with prostate cancer treated with orchiectomy","volume":"172","author":"Dickman","year":"2004","journal-title":"J Urol."},{"key":"2024020318013391600_bib11","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1200\/JCO.2004.00.6908","article-title":"Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol."},{"key":"2024020318013391600_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-5347(05)00033-9","article-title":"Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer","volume":"175","author":"Smith","year":"2006","journal-title":"J Urol."},{"key":"2024020318013391600_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med."},{"key":"2024020318013391600_bib14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1464-410X.2007.07163.x","article-title":"Fracture risk in Danish men with prostate cancer: a nationwide register study","volume":"100","author":"Abrahamsen","year":"2007","journal-title":"BJU Int."},{"key":"2024020318013391600_bib15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.juro.2007.05.135","article-title":"Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications","volume":"178","author":"Krupski","year":"2007","journal-title":"J Urol."},{"key":"2024020318013391600_bib16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0002-9343(02)01382-7","article-title":"Bone mass and the risk of prostate cancer: the Framingham Study","volume":"113","author":"Zhang","year":"2002","journal-title":"Am J Med."},{"key":"2024020318013391600_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1158\/1055-9965.EPI-08-0415","article-title":"The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) Study","volume":"18","author":"Farhat","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"2024020318013391600_bib18","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.2000.18.7.1570","article-title":"Osteoporosis due to cancer treatment: pathogenesis and management","volume":"18","author":"Pfeilschifter","year":"2000","journal-title":"J Clin Oncol."},{"key":"2024020318013391600_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/JBMR.041131","article-title":"Fracture risk with multiple myeloma: a population-based study","volume":"20","author":"Melton","year":"2005","journal-title":"J Bone Miner Res."},{"key":"2024020318013391600_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4065\/71.3.266","article-title":"History of the Rochester Epidemiology Project","volume":"71","author":"Melton","year":"1996","journal-title":"Mayo Clin Proc."},{"key":"2024020318013391600_bib21","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJM199711133372012","article-title":"The threat to medical-records research","volume":"337","author":"Melton","year":"1997","journal-title":"N Engl J Med."},{"key":"2024020318013391600_bib22","author":"U.S.D.H.H.S","year":"2004"},{"key":"2024020318013391600_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650070214","article-title":"Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985\u20131989","volume":"7","author":"Cooper","year":"1992","journal-title":"J Bone Miner Res."},{"key":"2024020318013391600_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s001980050113","article-title":"Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time","volume":"9","author":"Melton","year":"1999","journal-title":"Osteoporos Int."},{"key":"2024020318013391600_bib25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/biomet\/40.3-4.354","article-title":"Some simple approximate tests for Poisson variates","volume":"40","author":"Cox","year":"1953","journal-title":"Biometrika."},{"key":"2024020318013391600_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametic estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"2024020318013391600_bib27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med."},{"key":"2024020318013391600_bib28","volume-title":"The Statistical Analysis of Failure Time Data","author":"Kalbfleisch","year":"1980"},{"key":"2024020318013391600_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"2024020318013391600_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika."},{"key":"2024020318013391600_bib31","first-page":"4908","article-title":"Fracture risk in androgen deprivation therapy: a Canadian population based analysis","volume":"16","author":"Lau","year":"2009","journal-title":"Can J Urol."},{"key":"2024020318013391600_bib32","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jama.2010.1205","article-title":"Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction","volume":"304","author":"Psaty","year":"2010","journal-title":"JAMA."},{"key":"2024020318013391600_bib33","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1097\/01.ju.0000127738.94221.da","article-title":"Bicalutamide 150mg maintains bone mineral density during monotherapy for localized or locally advanced prostate cancer","volume":"171","author":"Sieber","year":"2004","journal-title":"J Urol."},{"key":"2024020318013391600_bib34","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.2004.01.174","article-title":"Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition","volume":"22","author":"Smith","year":"2004","journal-title":"J Clin Oncol."},{"key":"2024020318013391600_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hernan","year":"2010","journal-title":"Epidemiology."},{"key":"2024020318013391600_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","article-title":"Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis","volume":"148","author":"MacLean","year":"2008","journal-title":"Ann Intern Med."},{"key":"2024020318013391600_bib37","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/cncr.23452","article-title":"Limits of observational data in determining outcomes from cancer therapy","volume":"112","author":"Giordano","year":"2008","journal-title":"Cancer."},{"key":"2024020318013391600_bib38","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","article-title":"A meta-analysis of prior corticosteroid use and fracture risk","volume":"19","author":"Kanis","year":"2004","journal-title":"J Bone Miner Res."},{"key":"2024020318013391600_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00223-006-0060-0","article-title":"Methotrexate, azathioprine, cyclosporine, and risk of fracture","volume":"79","author":"Vestergaard","year":"2006","journal-title":"Calcif Tissue Int."},{"key":"2024020318013391600_bib40","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1001\/archinte.159.15.1750","article-title":"Long-term use of oral anticoagulants and the risk of fracture","volume":"159","author":"Caraballo","year":"1999","journal-title":"Arch Intern Med."},{"key":"2024020318013391600_bib41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","article-title":"A meta-analysis of previous fracture and subsequent fracture risk","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone."},{"key":"2024020318013391600_bib42","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s00198-005-1863-y","article-title":"Body mass index as a predictor of fracture risk: a meta-analysis","volume":"16","author":"De Laet","year":"2005","journal-title":"Osteoporos Int."},{"key":"2024020318013391600_bib43","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/S0022-5347(05)65661-3","article-title":"Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer","volume":"166","author":"Oefelein","year":"2001","journal-title":"J Urol."},{"key":"2024020318013391600_bib44","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00198-009-0840-2","article-title":"Pathologic\u201d fractures: should these be included in epidemiologic studies of osteoporotic fractures?","volume":"20","author":"Curtis","year":"2009","journal-title":"Osteoporos Int."},{"key":"2024020318013391600_bib45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00198-008-0742-8","article-title":"Secular trends in hip fracture incidence and recurrence","volume":"20","author":"Melton","year":"2009","journal-title":"Osteoporos Int."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.405","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/26\/8\/1808\/56558427\/405_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/26\/8\/1808\/56558427\/405_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:05:05Z","timestamp":1710342305000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/26\/8\/1808-1815\/7598025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,21]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,4,21]]},"published-print":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.405","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,8,1]]},"published":{"date-parts":[[2011,4,21]]}}}